Opin vísindi

Fletta eftir höfundi "Furu, Kari"

Fletta eftir höfundi "Furu, Kari"

Röðun: Raða: Niðurstöður:

  • Icon
    Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder : a Nordic cohort study 
    Hálfdánarson, Óskar; Cohen, Jacqueline M.; Karlstad, Øystein; Cesta, Carolyn E.; Bjørk, Marte Helene; Håberg, Siri Eldevik; Einarsdóttir, Kristjana; Furu, Kari; Gissler, Mika; Hjellvik, Vidar; Kieler, Helle; Leinonen, Maarit K.; Nørgaard, Mette; Öztürk Essen, Buket; Ulrichsen, Sinna Pilgaard; Reutfors, Johan; Zoega, Helga (2022-05-01)
    BACKGROUND: Antipsychotics are increasingly used among women of childbearing age and during pregnancy. OBJECTIVE: To determine whether children exposed to antipsychotics in utero are at increased risk of attention-deficit/hyperactivity disorder (ADHD) ...
  • Icon
    Association of Prenatal Exposure to Antiseizure Medication with Risk of Autism and Intellectual Disability 
    Bjørk, Marte Helene; Zoega, Helga; Leinonen, Maarit K.; Cohen, Jacqueline M.; Dreier, Julie Werenberg; Furu, Kari; Gilhus, Nils Erik; Gissler, Mika; Hálfdánarson, Óskar; Igland, Jannicke; Sun, Yuelian; Tomson, Torbjörn; Alvestad, Silje; Christensen, Jakob (2022-07-01)
    Importance: Women with epilepsy frequently need antiseizure medication (ASM) to prevent seizures in pregnancy. Risk of neurodevelopmental disorders after prenatal exposure to AMSs is uncertain. Objective: To determine whether children exposed prenatally ...
  • Icon
    Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations : A Multinational Study 
    Bröms, Gabriella; Hernandez-Diaz, Sonia; Huybrechts, Krista F.; Bateman, Brian T.; Kristiansen, Eskild Bendix; Einarsdóttir, Kristjana; Engeland, Anders; Furu, Kari; Gissler, Mika; Karlsson, Pär; Klungsøyr, Kari; Lahesmaa-Korpinen, Anna Maria; Mogun, Helen; Nørgaard, Mette; Reutfors, Johan; Sørensen, Henrik Toft; Zoega, Helga; Kieler, Helle (2023-01-16)
    Objective: Most research on safety of attention-deficit/hyperactivity disorder (ADHD) medications during pregnancy concerns central nervous system stimulants, while little is known about the safety of atomoxetine, a primary treatment alternative. We ...
  • Icon
    Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations 
    Cohen, Jacqueline M.; Alvestad, Silje; Cesta, Carolyn E.; Bjørk, Marte Helene; Leinonen, Maarit K.; Nørgaard, Mette; Einarsdóttir, Kristjana; Engeland, Anders; Gissler, Mika; Karlstad, Øystein; Klungsøyr, Kari; Odsbu, Ingvild; Reutfors, Johan; Selmer, Randi M.; Tomson, Torbjörn; Ulrichsen, Sinna Pilgaard; Zoega, Helga; Furu, Kari (2022-12-12)
    Objective: This study was undertaken to examine the comparative safety of antiseizure medication (ASM) monotherapy in pregnancy with respect to risk of major congenital malformations (MCMs), overall and by MCM subtype. Methods: We conducted a ...
  • Icon
    Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy 
    Cesta, Carolyn E.; Rotem, Ran; Bateman, Brian T.; Chodick, Gabriel; Cohen, Jacqueline M.; Furu, Kari; Gissler, Mika; Huybrechts, Krista F.; Kjerpeseth, Lars J.; Leinonen, Maarit K.; Pazzagli, Laura; Zoega, Helga; Seely, Ellen W.; Patorno, Elisabetta; Hernández-Díaz, Sonia (2024-02-05)
    Importance: Increasing use of second-line noninsulin antidiabetic medication (ADM) in pregnant individuals with type 2 diabetes (T2D) may result in fetal exposure, but their teratogenic risk is unknown. Objective: To evaluate periconceptional use of ...